Biotech firms now seek professionals who blend biology and AI expertise
Biotech companies are prioritizing candidates who can bridge biology and artificial intelligence, such as data scientists with life sciences knowledge. Computational biologists and AI engineers are also in high demand. The ability to connect scientific problems with AI solutions is becoming more critical than traditional job titles.
The article reports that 64% of surveyed organizations were actively hiring, with AI as a stated priority. Benchling's research identified data scientists possessing life sciences knowledge as the most sought-after role, followed by computational biologists with AI skills and AI engineers capable of deploying models. This reflects a broader shift in how biotech companies define essential expertise.
Computational biology roles are increasingly engineering-focused, requiring pipeline development and familiarity with modern machine-learning frameworks. Biological datasets present unique hurdles—they can be noisy, sparse, and expensive to produce—making reproducibility and data provenance as critical as model accuracy. Early applications of agentic AI in biomedical research, such as literature review and hypothesis generation, suggest this trend will continue reshaping hiring priorities.
This hiring shift could affect career trajectories across the life sciences, potentially creating advantages for professionals with interdisciplinary training while leaving traditional bench scientists needing retraining. Universities and employers may need to adapt curricula and development programs accordingly. For patients, the trend could accelerate drug discovery timelines and improve research efficiency, though transitional hiring bottlenecks may temporarily slow some programs.